Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs in rat hippocampal GABAergic interneurons.
Hippocampal inhibitory interneurons are a diverse population of cells widely scattered in the hippocampus, where they regulate hippocampal circuit activity. The hippocampus receives cholinergic projections from the basal forebrain, and functional studies have suggested the presence of different subtypes of nicotinic acetylcholine receptors (AChRs) on gamma-aminobutyric acid (GABA)ergic interneurons. Single-cell polymerase chain reaction analysis had confirmed that several nAChR subunit mRNAs are co-expressed with glutamate decarboxylase 67 (GAD67), the marker for GABAergic interneurons. In this anatomical study, we systematically investigated the co-expression of GAD67 with different nAChR subunits by using double in situ hybridization with a digoxigenin-labeled GAD67 probe and (35)S-labeled probes for nAChR subunits (alpha2, alpha3, alpha4, alpha5, alpha6, alpha7, beta2, beta3, and beta4). The results revealed that most GAD67-positive interneurons expressed beta2, and 67 % also expressed alpha7 mRNA. In contrast, mRNA expression of other subunits was limited; only 13 % of GAD67-positive neurons co-expressed alpha4, and less than 10% expressed transcripts for alpha2, alpha3, alpha5, or beta4. Most GAD67/alpha2 co-expression was located in CA1/CA3 stratum oriens, and GAD67/alpha5 co-expression was predominantly detected in CA1/CA3 stratum radiatum/lacunosum moleculare and the dentate gyrus. Expression of alpha6 and beta3 mRNAs was rarely detected in the hippocampus, and mRNAs were not co-expressed with GAD67. These findings suggest that the majority of nicotinic responses in GABAergic interneurons should be mediated by a homomeric alpha7 or heteromeric alpha7*-containing nAChRs. Other possible combinations such as alpha2beta2*, alpha4beta2*, or alpha5beta2* heteromeric nAChRs could contribute to functional nicotinic response in subsets of GABAergic interneurons but overall would have a minor role.
Son
Jong-Hyun
JH
Department of Neuroscience and Experimental Therapeutics, Texas A&M University System, Health Science Center, College Station, Texas 77843-1114, USA.
Winzer-Serhan
Ursula H
UH
D000818:Animals; D005968:Glutamate Decarboxylase / Q000235:genetics / Q000378:metabolism; D006624:Hippocampus / Q000166:cytology*; D017403:In Situ Hybridization; D007395:Interneurons / Q000166:cytology / Q000378:metabolism*; D008297:Male; D021122:Protein Subunits / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011978:Receptors, Nicotinic / Q000235:genetics / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D021122:Protein Subunits; D012333:RNA, Messenger; D011978:Receptors, Nicotinic; D005680:gamma-Aminobutyric Acid; D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1
Brain Res Bull. 1989 Feb;22(2):453-9
2706548
Prog Brain Res. 1989;79:27-33
2587747
Annu Rev Physiol. 1995;57:521-46
7778876
J Neurosci. 1998 Feb 15;18(4):1187-95
9454829
J Physiol. 2002 Apr 15;540(Pt 2):425-34
11956333
Neuroscience. 1994 Oct;62(3):929-44
7870314
Prog Neurobiol. 1991;37(6):475-524
1763188
Neuroscience. 2004;124(2):405-20
14980390
J Neurosci. 1985 May;5(5):1307-15
3998824
J Chem Neuroanat. 2006 Dec;32(2-4):179-90
17046198
J Physiol. 2000 Sep 15;527 Pt 3:515-28
10990538
Prog Brain Res. 2004;145:109-20
14650910
J Neurosci. 2001 Mar 1;21(5):1452-63
11222635
J Neurosci. 1993 Feb;13(2):596-604
7678857
J Neurophysiol. 2001 Dec;86(6):3043-55
11731559
J Comp Neurol. 1993 Mar 22;329(4):427-37
8454734
Annu Rev Neurosci. 1993;16:403-43
7681637
J Neurosci. 2001 Jan 1;21(1):RC120
11150356
Brain Res. 1998 Dec 14;814(1-2):55-70
9838044
J Pharmacol Exp Ther. 1993 Jun;265(3):1455-73
8510022
J Comp Neurol. 2005 Jan 3;481(1):19-30
15558717
J Comp Neurol. 1989 Jun 8;284(2):314-35
2754038
Nature. 1996 Mar 28;380(6572):347-51
8598930
Brain Res. 1990 Aug 27;526(1):45-53
2078817
J Neurosci. 1993 May;13(5):1965-75
8478687
J Pharmacol Exp Ther. 1995 Nov;275(2):1030-4
7473129
J Neurosci. 1999 Apr 15;19(8):2887-96
10191306
Eur J Neurosci. 2007 May;25(9):2666-81
17466021
J Neurosci. 1999 Nov 15;19(22):10140-52
10559422
J Comp Neurol. 2002 Mar 12;444(3):260-74
11840479
J Neurophysiol. 2000 May;83(5):2682-90
10805668
J Biol Chem. 1997 Sep 19;272(38):24024-9
9295355
Neuroscience. 2003;119(4):965-77
12831856
Trends Neurosci. 1999 Dec;22(12):555-61
10542436
J Pharmacol Exp Ther. 1997 Dec;283(3):1396-411
9400016
J Comp Neurol. 1985 Sep 8;239(2):237-46
4044938
J Comp Neurol. 1997 Oct 6;386(4):540-54
9378850
Neuroscience. 1997 Mar;77(1):87-96
9044377
Prog Brain Res. 2004;145:95-107
14650909
Hippocampus. 1996;6(4):347-470
8915675
J Physiol. 1997 Nov 1;504 ( Pt 3):603-10
9401968
Biochem Pharmacol. 2007 Oct 15;74(8):1134-44
17645875
Neuron. 1989 Oct;3(4):487-96
2642007
Brain Res Dev Brain Res. 2002 Dec 15;139(2):175-87
12480132